Quality of life (QoL) in patients with metastatic pancreatic cancer receiving first-line Nab-paclitaxel/gemcitabine chemotherapy: Results of the large QoL study AIO-QoliXane/PARAGON

Autor:	Rudolf Schlag, Joerg Trojan, Joerg E. A. Schubert, Gabriele Margareta Siegler, Nils Homann, S. Dörfel, Mark-Oliver Zahn, H.-G. Höffkes, S.-E. Al-Batran, Oliver Waidmann, G. zur Hausen, T.O. Götze, Alexander Reichart, Claudia Pauligk, Ali Aldaoud, Wolfgang Blau, Lars Hahn, C. Schönherr, M. Reiser, Michael Koenigsmann
Rok vydání:	2018
Předmět:	Oncology medicine.medical_specialty Chemotherapy business.industry First line medicine.medical_treatment Hematology Gemcitabine Quality of life Internal medicine Metastatic pancreatic cancer medicine In patient business medicine.drug Nab-paclitaxel
Zdroj:	Web of Science
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy282.122
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063e8ab474dd869b0479cebdcecc018e https://doi.org/10.1093/annonc/mdy282.122 Zobrazit plný text záznamu